Author
Listed:
- Ann M. Ranger
(Harvard Medical School)
- Michael J. Grusby
(Harvard Medical School)
- Martin R. Hodge
(Harvard Medical School
Millennium Pharmaceuticals)
- Ellen M. Gravallese
(Harvard Medical School)
- Fabienne Charles de la Brousse
(Tularik Inc)
- Tim Hoey
(Tularik Inc)
- Craig Mickanin
(Children's Hospital of Philadelphia)
- H. Scott Baldwin
(Children's Hospital of Philadelphia)
- Laurie H. Glimcher
(Harvard Medical School)
Abstract
Nuclear factor of activated T cells (NF-AT) is the name of a family of four related transcription factors that may be needed for cytokine gene expression in activated lymphocytes1,2,3,4. Here we report that mice with a targeted disruption of the NF-ATc gene show an unexpected and dramatic defect in cardiac morphogenesis, with selective absence of the aortic and pulmonary valves, leading to death in utero from congestive heart failure at days 13.5–17.5 of gestation. In contrast, tricuspid and mitral valve morphogenesis is normal. NF-ATc is the first transcription factor known to be expressed only in the endothelial cells of the heart. As in T cells, nuclear translocation of NF-ATc in cardiac endothelial cells is controlled by the calcium-regulated phosphatase calcineurin5,6: NF-ATc remains cytoplasmic in normal embryos cultured with cyclosporin A, an inhibitor of calcineurin. Abnormal development of the cardiac valves and septae is the most frequent form of birth defect, yet few molecular regulators of valve formation are known. Our results indicate that NF-ATc may play a critical role in signal-transduction processes required for normal cardiac valve formation.
Suggested Citation
Ann M. Ranger & Michael J. Grusby & Martin R. Hodge & Ellen M. Gravallese & Fabienne Charles de la Brousse & Tim Hoey & Craig Mickanin & H. Scott Baldwin & Laurie H. Glimcher, 1998.
"The transcription factor NF-ATc is essential for cardiac valve formation,"
Nature, Nature, vol. 392(6672), pages 186-190, March.
Handle:
RePEc:nat:nature:v:392:y:1998:i:6672:d:10.1038_32426
DOI: 10.1038/32426
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:392:y:1998:i:6672:d:10.1038_32426. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.